Figure 3.
EFS of patients according to clonal interference of signaling mutations in CBF AML subsets. t(8;21) patients (n = 230) (A) and inv(16) patients (n = 215) (B). EFS is censored at HSCT in first CR.
EFS of patients according to clonal interference of signaling mutations in CBF AML subsets. t(8;21) patients (n = 230) (A) and inv(16) patients (n = 215) (B). EFS is censored at HSCT in first CR.
